[1]
I. Ali, “RESPONSE RATE OF SOFOSBUVIR BASED ANTIVIRAL THERAPY AMONG PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 3A”, Jmedsci, vol. 27, no. 4, pp. 295-301, Dec. 2019.